6th Edition of World Congress on Infectious Diseases
June 24-26, 2024 | Paris, France
Research on Medicine and Vaccine for Covid-19
COVID-19 has claimed the lives of about 18 million people. Researchers are working around the clock to better understand, cure, and finally eradicate COVID-19 and the sickness that comes with it. WHO and its partners are dedicated to developing COVID-19 vaccines as quickly as possible while maintaining the highest safety requirements. Vaccines go through several stages of research and testing - clinical trials typically have three phases, the last of which is aimed to examine the product's capacity to protect against disease, known as effectiveness. Each phase evaluates the level of risk. Vaccines have previously been developed through a sequence of steps that can take years to complete. Given the critical need for COVID-19 vaccines, enormous financial investments and scientific collaborations are now transforming vaccine development.
- Antivirals
- Vaccines
- Clinical Trials
Submit your abstract Today
Title : Antiretroviral resistance among HIV-infected patients in the upper southern region of Thailand
Siwimol Phoomniyom, The Office of Prevention and Disease Control 11th Region, Thailand
Title : Iron in virulency and pathogenesis of Leishmania donovani
Priya Priydarshni, ICMR-RMRIMS, India
Title : Strongyloides hyperinfection in covid-19 patients treated with corticosteroids: A systematic review
Sana Zulfiqar, Trinity College Dublin, Ireland
Title : Crosstalk between Unfold Protein Response, autophagy and apoptosis in host cells infected with street rabies virus
Farzaneh Sheikholeslami, WHO Collaborating Center for Reference and Research on Rabies in Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Genomic analysis of WGS of Leishmania major
El Bakri Fatimazahrae , University Ibn Tofail , Morocco
Title : Fight against measles and rubella in Morocco: Evaluative study
Kharti Kawtar, doctoral study center-Ibn Tofail University, Morocco